These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 18268052)
1. Genetic adjuvant therapy for pancreatic cancer and other solid tumours. Bagley KC Gut; 2008 Mar; 57(3):289-91. PubMed ID: 18268052 [No Abstract] [Full Text] [Related]
2. Gene therapy and pancreatic cancer. Clary BM; Lyerly HK Surg Oncol Clin N Am; 1998 Jan; 7(1):217-49. PubMed ID: 9443997 [TBL] [Abstract][Full Text] [Related]
3. A "friendly merger" in the war on cancer. Sadelain M Mol Ther; 2000 Feb; 1(2):115-6. PubMed ID: 10933920 [No Abstract] [Full Text] [Related]
4. Current status of gene therapy for pancreatic cancer. RamÃrez PJ; Vickers SM Curr Surg; 2004; 61(1):84-92. PubMed ID: 14972178 [TBL] [Abstract][Full Text] [Related]
6. [Present status of and prospects for basic research on pancreatic cancer]. Zhao YP; Zhang TP Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1945-7. PubMed ID: 19062731 [No Abstract] [Full Text] [Related]
7. [Update in the research of gene therapy for pancreatic carcinoma]. Wang M; Wang YL; Lei RQ; Feng DX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):648-53. PubMed ID: 16274052 [TBL] [Abstract][Full Text] [Related]
8. Silencing RNA: a novel treatment for pancreatic cancer? Lemoine NR Gut; 2005 Sep; 54(9):1215-6. PubMed ID: 16099788 [No Abstract] [Full Text] [Related]
9. Immunotherapy synergizes with chemotherapy targeting pancreatic cancer. Koido S; Homma S; Takahara A; Namiki Y; Komita H; Uchiyama K; Ito M; Gong J; Ohkusa T; Tajiri H Immunotherapy; 2012 Jan; 4(1):5-7. PubMed ID: 22149993 [No Abstract] [Full Text] [Related]
11. [Gene therapy for pancreatic cancer]. Yoshida T; Aoki K Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2727-31. PubMed ID: 8584728 [No Abstract] [Full Text] [Related]
12. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers. Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer. Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316 [TBL] [Abstract][Full Text] [Related]
15. Search for "weapons of mass destruction" for cancer -- immuno/ gene therapy comes of age. Wei MQ; Metharom P; Ellem KA; Barth S Cell Mol Immunol; 2005 Oct; 2(5):351-7. PubMed ID: 16368061 [TBL] [Abstract][Full Text] [Related]
16. Surgical resection after TNFerade therapy for locally advanced pancreatic cancer. Chadha MK; Litwin A; Levea C; Iyer R; Yang G; Javle M; Gibbs JF JOP; 2009 Sep; 10(5):535-8. PubMed ID: 19734632 [TBL] [Abstract][Full Text] [Related]
17. Cancer gene therapy steadily advances. Brower V J Natl Cancer Inst; 2008 Sep; 100(18):1276-8. PubMed ID: 18780858 [No Abstract] [Full Text] [Related]
18. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma. Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144 [TBL] [Abstract][Full Text] [Related]